These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3080225)

  • 1. Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamil.
    Darkin S; Ralph RK
    Cancer Lett; 1986 Jan; 30(1):25-33. PubMed ID: 3080225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of AMSA drugs into cells.
    Darkin S; Ralph RK
    FEBS Lett; 1985 Oct; 190(2):349-53. PubMed ID: 3930297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reassessment of the mechanism of action of 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide.
    Marshall B; Ralph RK
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):553-7. PubMed ID: 6811280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that mAMSA induces topoisomerase action.
    Marshall B; Darkin S; Ralph RK
    FEBS Lett; 1983 Sep; 161(1):75-8. PubMed ID: 6309576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocked 5'-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide (mAMSA).
    Marshall B; Ralph RK; Hancock R
    Nucleic Acids Res; 1983 Jun; 11(12):4251-6. PubMed ID: 6306581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of the DNA intercalating agents 4'-(9-acridinylamino) methanesulphon-m-anisidide and 1,4-bis(butylamino) benzo[g]phthalazine in U-937 human promonocytic cells: relationship between cell cycle and differentiation.
    Pérez C; Campayo L; Navarro P; García-Bermejo L; Aller P
    Biochem Pharmacol; 1994 Jul; 48(1):75-82. PubMed ID: 7519013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of action of 4'-[(9-acridinyl)-amino] methanesulphon-m-anisidide.
    Ralph RK
    Eur J Cancer (1965); 1980 May; 16(5):595-600. PubMed ID: 6771143
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxyribonucleic acid breaks produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper.
    Wong A; Huang CH; Crooke ST
    Biochemistry; 1984 Jun; 23(13):2939-45. PubMed ID: 6205684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of the intercalating agent 4'-(9-acridylamino)-methanesulphon-m -anisidide to induce DNA-repair replication in cultured human cells.
    Wilkins RJ
    Mutat Res; 1983 Nov; 122(2):211-6. PubMed ID: 6689200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
    Zwelling LA; Kerrigan D; Marton LJ
    Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of deoxyribonucleic acid breakage induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper: role for cuprous ion and oxygen free radicals.
    Wong A; Huang CH; Crooke ST
    Biochemistry; 1984 Jun; 23(13):2946-52. PubMed ID: 6087883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the active species in deoxyribonucleic acid breakage induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper.
    Wong A; Cheng HY; Crooke ST
    Biochem Pharmacol; 1986 Apr; 35(7):1071-8. PubMed ID: 3754443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II clinical study of mAMSA in small cell carcinoma of the lung.
    Dady PJ; Sappino AP; Rudd A; Smith IE
    Cancer Chemother Pharmacol; 1981; 6(2):195-6. PubMed ID: 6273006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the thiol adducts of 4'-(9-acridinylamino)methanesulfon-m-anisidide and their binding to deoxyribonucleic acid.
    Wong A; Huang CH; Hwang SM; Prestayko AW; Crooke ST
    Biochem Pharmacol; 1986 May; 35(10):1655-62. PubMed ID: 3754750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of viral growth by the antitumor drug 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA).
    Drake S; Furlong NB; Nelson JA
    Biochem Pharmacol; 1983 Sep; 32(17):2615-8. PubMed ID: 6688528
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced DNA break formation and cytotoxicity of the topoisomerase II drug 4'-(9'-acridinylamino)methanesulfon-m-anisidide when combined with hyperthermia in human and rodent cell lines.
    Kampinga HH; van den Kruk G; Konings AW
    Cancer Res; 1989 Apr; 49(7):1712-7. PubMed ID: 2538233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of DNA breakage by 4'-[(9-acridinyl)amino]methane-sulphone-m-anisidide.
    Marshall B; Ralph RK
    FEBS Lett; 1982 Aug; 145(2):187-90. PubMed ID: 6290268
    [No Abstract]   [Full Text] [Related]  

  • 18. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
    Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.